Stress study in adults with heart failure using a heart monitor
Part of Heart & circulation clinical trials.
This study looks at how stress affects blood pressure patterns in people with heart failure, using an implanted CardioMEMS pressure monitor. It may help doctors understand whether stress changes heart failure symptoms and pressure readings over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older and have heart failure.
- Have a CardioMEMS implanted pressure monitor to track your lung/heart pressures (or be scheduled to receive one).
- Be able to complete daily check-ins (EMA) and lab/assessment visits.
- You should not have the most severe (Class IV) heart failure.
- Your case should not have other problems that can also affect pressure readings (for example, dialysis).
- You should be able to participate consistently, including staying compliant with your CardioMEMS monitoring; you should not have long-term opioid use.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at how well the CardioMEMS heart monitor works for people with heart failure. The device is already implanted and tracks pressure in your lung artery to help your doctor manage your condition and potentially prevent hospital visits.
This study looks at how a small monitor inside the blood vessel to the lungs helps manage heart failure. It aims to improve care for people with advanced heart failure.
This study tests whether a wearable device that monitors your heart and transmits data to your doctor can help optimize your heart failure medications after hospitalization. The goal is to prevent future hospital visits and improve your health by keeping closer tabs on how your body responds to treatment adjustments.
This trial tests how well a heart stress ultrasound (dobutamine echo) can predict if you will get better from a special heart device called cardiac contractility modulation (CCM). CCM is a pacemaker-like implant for people with advanced heart failure who still have symptoms even with the best medicines. The study will help doctors know which patients benefit the most from this device.
This study checks how safe a small heart-pressure monitoring device is for people with advanced heart failure and severe kidney problems. It looks at whether doctors can continuously track heart filling/pressure to help manage symptoms and reduce risks.
This trial tests a home monitoring system called Cardiosignal to help manage heart failure after an emergency room visit. It may help doctors adjust your treatments to keep you healthier at home.
Hear when a new Congestive Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.